Maria L. Agostini

机构：VIR Biotechnology (United States)

发表论文 30 篇 · 总被引 5964 次 · h-index 20

代表论文

• An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice (2020 · Science Translational Medicine · 被引 1168)
• SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape (2021 · Nature · 被引 598)
• Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice (2020 · Cell Reports · 被引 541)
• SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern (2021 · Science · 被引 465)
• Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies (2021 · Nature · 被引 328)
• The coronavirus proofreading exoribonuclease mediates extensive viral recombination (2021 · PLoS Pathogens · 被引 291)